Qube Research & Technologies (QRT)
LUCD icon

Qube Research & Technologies (QRT)’s Lucid Diagnostics LUCD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-103
Closed -$85 – 3779
2024
Q2 		$85 Buy
103
+102
+10,200% +$86 ﹤0.01% 3445
2024
Q1 		$1 Sell
1
-103
-99% -$134 ﹤0.01% 4382
2023
Q4 		$147 Hold
104
– – ﹤0.01% 3998
2023
Q3 		$122 Buy
+104
New +$151 ﹤0.01% 3756

Other funds holding LUCD

LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LUCD Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Lucid Diagnostics (LUCD) in Q3 2024, closing a stake of 103 shares — an estimated $85 sold.

Qube Research & Technologies (QRT) first reported a position in LUCD in Q3 2023 and held it in 4 quarters. The position peaked at $147 in Q4 2023. 29 funds tracked by Wall St. Rank hold LUCD as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Lucid Diagnostics position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 103 Lucid Diagnostics shares in Q3 2024, an estimated $85.
  • Qube Research & Technologies (QRT) first reported a position in Lucid Diagnostics in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Lucid Diagnostics position peaked at $147 in Q4 2023.
  • 29 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.